A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
✍ Scribed by Gary S. Hoffman; Maria C. Cid; David B. Hellmann; Loic Guillevin; John H. Stone; John Schousboe; Pascal Cohen; Leonard H. Calabrese; Howard Dickler; Peter A. Merkel; Paul Fortin; John A. Flynn; Geri A. Locker; Kirk A. Easley; Eric Schned; Gene G. Hunder; Michael C. Sneller; Carol Tuggle; Howard Swanson; J. Hernández-Rodríguez; Alfons Lopez-Soto; Debora Bork; Diane B. Hoffman; Kenneth Kalunian; David Klashman; William S. Wilke; Raymond J. Scheetz; Brian F. Mandell; Barri J. Fessler; Gregory Kosmorsky; Richard Prayson; Raashid A. Luqmani; George Nuki; Euan McRorie; Yvonne Sherrer; Shawn Baca; Bridgit Walsh; Diane Ferland; Martin Soubrier; Hyon K. Choi; Wolfgang Gross; Allen M. Segal; Charles Ludivico; Xavier Puechal; International Network for the Study of Systematic Vasculitides (INSSYS)
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 105 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin
## Abstract ## Objective Glucocorticoid (GC) therapy for giant cell arteritis (GCA) is effective but requires prolonged administration, resulting in adverse side effects. The goal of the current study was to test the hypothesis that induction treatment with high‐dose pulse intravenous (IV) methylp
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex